Archives of Neuroscience

Published by: Kowsar

Transcranial Sonography (TCS) and Extrapyramidal Diseases: An Evolving Story

Enzo Sanzaro 1 , *
Author Information
1 Department of Neurology, Guzzardi Hospital, Vittoria, Ragusa, Italy
Article information
  • Archives of Neuroscience: July 01, 2016, 3 (3); e34579
  • Published Online: February 13, 2016
  • Article Type: Editorial
  • Received: November 11, 2015
  • Revised: November 17, 2015
  • Accepted: November 21, 2015
  • DOI: 10.5812/archneurosci.34579

To Cite: Sanzaro E. Transcranial Sonography (TCS) and Extrapyramidal Diseases: An Evolving Story, Arch Neurosci. 2016 ; 3(3):e34579. doi: 10.5812/archneurosci.34579.

Copyright © 2016, Tehran University of Medical Sciences. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License ( which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
  • 1. Behnke S, Berg D, Naumann M, Becker G. Differentiation of Parkinson's disease and atypical parkinsonian syndromes by transcranial ultrasound. J Neurol Neurosurg Psychiatry. 2005; 76(3): 423-5[DOI][PubMed]
  • 2. Berg D, Godau J, Walter U. Transcranial sonography in movement disorders. The Lancet Neurology. 7(11): 1044-55[DOI][PubMed]
  • 3. Kolevski G, Petrov I, Petrova V. Transcranial sonography in the evaluation of Parkinson disease. J Ultrasound Med. 2007; 26(4): 509-12[PubMed]
  • 4. Spiegel J, Hellwig D, Mollers MO, Behnke S, Jost W, Fassbender K, et al. Transcranial sonography and [123I]FP-CIT SPECT disclose complementary aspects of Parkinson's disease. Brain. 2006; 129: 1188-93[DOI][PubMed]
  • 5. Martin WR, Wieler M, Gee M. Midbrain iron content in early Parkinson disease: a potential biomarker of disease status. Neurology. 2008; 70(16 Pt 2): 1411-7[DOI][PubMed]
  • 6. Zecca L, Berg D, Arzberger T, Ruprecht P, Rausch WD, Musicco M, et al. In vivo detection of iron and neuromelanin by transcranial sonography: a new approach for early detection of substantia nigra damage. Mov Disord. 2005; 20(10): 1278-85[DOI][PubMed]
  • 7. Michell AW, Lewis SJ, Foltynie T, Barker RA. Biomarkers and Parkinson's disease. Brain. 2004; 127: 1693-705[DOI][PubMed]
  • 8. Gaenslen A, Unmuth B, Godau J, Liepelt I, Di Santo A, Schweitzer KJ, et al. The specificity and sensitivity of transcranial ultrasound in the differential diagnosis of Parkinson's disease: a prospective blinded study. Lancet Neurol. 2008; 7(5): 417-24[DOI][PubMed]
  • 9. Rocchi L, Niccolini F, Politis M. Recent imaging advances in neurology. J Neurol. 2015; 262(9): 2182-94[DOI][PubMed]
  • 10. Sanzaro E, Iemolo F, Duro G, Malferrari G. A new assessment tool for Parkinson disease: the nigral lesion load obtained by transcranial sonography. J Ultrasound Med. 2014; 33(9): 1635-40[DOI][PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .
Readers' Comments